Diovan for paediatric use

Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to include treatment of hypertension in children and adolescents, 6 to 18 years of age.

Use of Diovan for this indication is extensively monitored by the Commission on Human Medicines (CHM) and the Medicines and Healthcare products Regulatory Agency (MHRA) and any adverse reactions should be reported when prescribed to children or adolescents with hypertension.

View Diovan drug record

Further information: Novartis

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more